A redux of schizophrenia research in 2021
- PMID: 35300898
- PMCID: PMC8919807
- DOI: 10.1016/j.schres.2022.03.003
A redux of schizophrenia research in 2021
Conflict of interest statement
None of the authors have any conflicts of interest to declare.
References
-
- Alqarni A., Mitchell T.W., McGorry P.D., Nelson B., Markulev C., Yuen H.P., Schäfer M.R., Berger M., Mossaheb N., Schlögelhofer M., Smesny S., Hickie I.B., Berger G.E., Chen E.Y.H., de Haan L., Nieman D.H., Nordentoft M., Riecher-Rössler A., Verma S., Thompson A., Yung A.R., Amminger G.P., Meyer B.J. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people. Schizophr. Res. 2020;226:44–51. doi: 10.1016/j.schres.2019.06.020. - DOI - PubMed
-
- Alqarni A., Mitchell T.W., McGorry P.D., Nelson B., Markulev C., Yuen H.P., Schäfer M.R., Berger M., Mossaheb N., Schlögelhofer M., Smesny S., Hickie I.B., Berger G.E., Chen E.Y.H., de Haan L., Nieman D.H., Nordentoft M., Riecher-Rössler A., Verma S., Thompson A., Yung A.R., Meyer B.J., Amminger G.P. Supplementation with the omega-3 long chain polyunsaturated fatty acids: changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis. Schizophr. Res. 2020;226:52–60. doi: 10.1016/j.schres.2019.08.033. Biomarkers in the Attenuated Psychosis Syndrome. - DOI - PubMed
-
- Bilgrami Z.R., Sarac C., Srivastava A., Herrera S.N., Azis M., Haas S.S., Shaik R.B., Parvaz M.A., Mittal V.A., Cecchi G., Corcoran C.M. Construct validity for computational linguistic metrics in individuals at clinical risk for psychosis: associations with clinical ratings. Schizophr. Res. 2022 doi: 10.1016/j.schres.2022.01.019. S0920-9964(22)00029–9. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical